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This study assessed the participation of amphiregulin (AREG) and bone 2 
morphogenetic protein 15 (BMP15) during maturation of bovine cumulus oocyte 3 
complexes (COCs) on cumulus cell function and their impact on subsequent embryo 4 
development. AREG treatment of COCs enhanced blastocyst formation and quality only 5 
when in the presence of BMP15. Expression of hyaluronan synthase 2 was enhanced 6 
by follicle stimulating hormone (FSH) but not by AREG, which was reflected in the level 7 
of cumulus expansion. Although both FSH and AREG stimulated glycolysis, AREG-8 
treated COCs had higher glucose consumption, lactate production and ratio of lactate 9 
production to glucose uptake. Autofluorescence levels in oocytes, indicative of NAD(P)H 10 
and FAD++, were increased with combined AREG and BMP15 treatment of COCs. In 11 
contrast, these treatments did not alter autoflouresence levels when cumulus cells were 12 
removed from oocytes, even in the presence of other COCs, suggesting oocyte-cumulus 13 
gap-junctional communication (GJC) is required. FSH contributed to maintaining GJC for 14 
an extended period of time. Remarkably, BMP15 was equally effective at maintaining 15 
GJC even in the presence of AREG. Hence, AREG stimulation of COC glycolysis and 16 
BMP15 preservation of GJC may facilitate efficient transfer of metabolites from cumulus 17 
cells to the oocyte thereby enhancing oocyte developmental competence. These results 18 









        Oocytes from in vitro maturation (IVM) have reduced developmental 2 
competence in clinical settings. To improve IVM outcomes and hence the clinical update 3 
of the procedure, understanding of the mechanisms regulating oocyte developmental 4 
competence and how these are impacted by IVM is imperative.  5 
Complex cellular processes occur during oocyte maturation within the ovarian 6 
follicular environment that determine the oocyte’s developmental competence, defined 7 
as the capacity of the oocyte to support fertilization and early embryo development 8 
(Gilchrist and Thompson, 2007). Significantly, this underpins fetal and neonatal 9 
development, postnatal health and prevention of programmable diseases (Gilchrist and 10 
Thompson, 2007, Mtango et al. , 2008). Oocyte maturation is coordinated by follicular 11 
cells, including granulosa and cumulus cells. These respond to stimulation by 12 
gonadotrophins (luteinizing hormone (LH) and follicle stimulating hormone (FSH)), which 13 
in turn interact with a complex array of local growth factors. How these signaling 14 
processes within the somatic cell compartment of the ovarian follicle endow the oocyte 15 
with developmental competence is a subject of intensive research, as these processes 16 
set the life course of healthy development and provides opportunities for clinical 17 
interventions to treat infertility.  18 
Oocyte maturation occurs during the period between the LH surge and 19 
ovulation. LH, via the cyclic adenosine 3′,5′-monophosphate (cAMP)-dependent pathway, 20 
induces a rapid and transient expression of epidermal growth factor (EGF)-like factors 21 
amphiregulin (AREG), epiregulin (EREG), and betacellulin (BTC), which are ligands for 22 
the EGF receptor (EGFR) as well as other members of the ErbB family in both mural 23 
granulosa and cumulus cells, thereby inducing maturation of the cumulus-oocyte 24 
complex (COC) (Hsieh et al. , 2007, Park et al. , 2004, Shimada et al. , 2006). EGF-like 25 





they trigger resumption of meiosis (Downs and Chen, 2008). During the maturation of 1 
COCs, extracellular signal-regulated kinases 1 and 2 (ERK1/2), phosphoinositide 3-2 
kinase (PI3K)/Akt and p38 mitogen-activated protein kinase (p38 MAPK) have been 3 
identified as downstream effectors of EGFR signaling in cumulus cells following ligand 4 
binding (Prochazka et al. , 2012, Shimada et al., 2006, Yamashita et al. , 2007). 5 
Furthermore, EGF-like factors stimulate gene expression in cumulus cells that enable 6 
the production of hyaluronic acid and its organization within the extracellular matrix. 7 
Together, these promote modification and expansion of COCs which is essential for 8 
ovulation, but not for oocyte developmental competence. 9 
Oocyte-secreted factors (OSFs) such as bone morphogenetic protein 15 10 
(BMP15) (Laitinen et al. , 1998) and growth differentiation factor 9 (GDF9) (Dong et al. , 11 
1996), which are members of the transforming growth factor beta (TGF-β) superfamily, 12 
are required for correct differentiation of cumulus cells which is crucial for normal oocyte 13 
maturation (Eppig, 2001, Gilchrist et al. , 2006). OSFs regulate proliferation (Li et al. , 14 
2000), gene expression (Paradis et al. , 2010, Regassa et al. , 2011), luteinization (Eppig 15 
et al. , 1997), apoptosis (Hussein et al. , 2005) and expansion of the extra-cellular matrix 16 
(Buccione et al. , 1990) within cumulus cells. In the mouse, GDF9 and BMP15 regulate 17 
EGFR expression in cumulus cells (Su et al. , 2010). Furthermore, in granulosa and 18 
cumulus cells, GDF9 requires the activation of EGFR-ERK1/2 signaling (Sasseville et 19 
al. , 2010), suggesting that oocyte paracrine signals work cooperatively with EGFR 20 
signaling to regulate the function of follicular cells in the somatic compartment of the 21 
follicle.  22 
Previous studies have indicated that FSH, AREG and EREG enhance oocyte 23 
developmental competence (Demeestere et al. , 2012, Prochazka et al. , 2011, Richani 24 
et al. , 2013). Interestingly, COCs cultured with EGF-like factors have higher 25 





FSH, LH and equine chorionic gonadotrophin (Prochazka et al., 2011, Richani et al., 1 
2013).  2 
Bmp15 and/or Gdf9 null mice exhibit reduced fertility, at least in part due to 3 
impaired functions of granulosa cells and lower developmental competence of oocytes 4 
(Su et al. , 2004). In addition, we have demonstrated that supplementation of 5 
recombinant BMP15 or GDF9 during in vitro maturation of COCs significantly improves 6 
oocyte developmental competence, as assessed by increased blastocyst and fetal yield 7 
and blastocyst cell number (Hussein et al. , 2006, Yeo et al. , 2008). This may be related 8 
to the observation that, in the mouse at least, IVM oocytes are deficient in processed 9 
BMP15, relative to in vivo matured oocytes (unpublished data) 10 
Gonadotrophins and OSFs also regulate some of the metabolic processes that 11 
occur within follicular cells to support oocyte maturation. FSH stimulates glucose uptake 12 
by PI3K-mediated translocation of glucose transporter 4 protein to the membrane of 13 
granulosa cells (Roberts et al. , 2004). Endogenous OSFs control amino acid uptake 14 
(Eppig et al. , 2005), cholesterol biosynthesis (Su et al. , 2008) and glycolysis in cumulus 15 
cells (Sugiura et al. , 2007). These processes are important for metabolite supply to the 16 
oocyte, which may be mediated via cumulus-oocyte gap junctions that are regulated by 17 
FSH (Sommersberg et al. , 2000) as well as by local paracrine signals.  18 
In the present study, our aim was to investigate the mechanisms underpinning 19 
how EGF-like factors and OSFs act together to regulate bovine oocyte developmental 20 
competence. First, we examined the effect of AREG in the presence of native OSFs and 21 
the recombinant OSFs, human GDF9 and human BMP15, on oocyte meiotic maturation, 22 
in vitro development and blastocyst cell number. Our results indicate that AREG 23 
cooperates with BMP15 to enhance oocyte developmental competence. To gain further 24 
understanding of the improved oocyte developmental competence, we examined the 25 





transcripts encoding such as hyaluronic acid 2 (HAS2), tumor necrosis factor alpha-1 
induced protein 6 (TNFAIP6), pentraxin 3 (PTX3) and prostaglandin-endoperoxide 2 
synthase 2 (PTGS2); COC metabolism such as glycolysis and levels of autofluorescence 3 
within the oocyte, indicative of the metabolic coenzymes reduced nicotinamide adenine 4 
dinucleotide (phosphate) (NAD(P)H) and oxidized flavin adenine dinucleotide (FAD++).  5 
The effect of AREG and BMP15 on gap-junctional communication (GJC) between 6 
cumulus cells and the oocyte was assessed. 7 
 8 
Materials and Methods 9 
Chemicals and culture media 10 
Unless specified, chemicals were purchased from Sigma-Aldrich (St. Louis, 11 
MO). Oocyte in vitro maturation (IVM) medium was bicarbonate buffered TCM 199 (B-12 
199, ICN Biochemicals, Irvine, CA, USA) supplemented with 4 mg/ml of fatty-acid free 13 
bovine serum albumin (FAF-BSA; ICP biological; Auckland, New Zealand), 0.5 mM 14 
pyruvate and kanamycin sulphate (0.1 mg/ml). Wash medium was VitroWash (IVF Vet 15 
Solutions, Adelaide, SA Australia) plus 4 mg/ml of FAF-BSA. In vitro fertilization (IVF) 16 
medium was VitroFert (IVF Vet Solutions) plus 4 mg/ml FAF-BAS. Embryo cleavage and 17 
blastocyst media were VitroCleave (IVF Vet Solutions) plus 4 mg/ml FAF-BSA and 18 
VitroBlast (IVF Vet Solutions) plus 4 mg/ml FAF-BSA, respectively. 19 
 20 
Oocyte collection and in vitro maturation 21 
Collection and IVM of bovine COCs was performed as previously described 22 
(Sutton-McDowall et al. , 2012). Bovine ovaries from a slaughterhouse were transferred 23 
to the laboratory, and then washed and stored in physiological saline at 38.5°C. COCs 24 
were aspirated from small follicles (2-6 mm in diameter) using a 10-ml syringe equipped 25 





(HEPES-buffered TCM199; ICP biological) supplemented with 4 mg/ml of FAF-BSA. 1 
Compact COCs with greater than 3 layers of cumulus cells and a homogeneous ooplasm 2 
were washed twice with HEPES-TCM 199. COCs were cultured in IVM medium without 3 
ligand addition (control), with 0.1 IU/ml FSH (Puregon; Organon, Oss, The Netherlands) 4 
(FSH), or with 100 ng/ml recombinant human amphiregulin (AREG; R&D systems, 5 
Minneapolis, MN, USA) in the presence or absence of DOs (0.5 oocyte/µl), 100 ng/ml of 6 
human GDF9 or 100 ng/ml of human BMP15. GDF9 and BMP15 were produced in our 7 
laboratory as concentrated preparations of the pro- and mature-region complexes, 8 
produced in 293T cells, as previously described (Pulkki et al. , 2012, Pulkki et al. , 2011). 9 
Ten COCs were incubated in 100 µl of IVM medium, covered with paraffin oil in 35-mm 10 
Petri dishes at 38.5°C for 22 h in a humidified atmosphere with 6% CO2 in air. About 20 11 
COCs were used per treatment per replicate. 12 
 13 
Assessment of meiotic status 14 
Following IVM for 22 h, COCs were mechanically denuded by pipetting and then 15 
fixed using 4% paraformaldehyde for 1 h at 4 °C. Fixed oocytes were incubated in a 16 
permeating solution (0.5% triton X-100 and 0.5% sodium citrate) for 15-30 min, followed 17 
by incubation in 3 μM 4′,6-diamidino-2-phenylindole solution in the dark for 15 minutes. 18 
Oocytes were washed in phosphate buffered saline (PBS) containing 1 mg/ml BSA and 19 
then mounted on a slide with glycerol. Chromosome configurations were assessed using 20 
a Nikon Eclipse TE2000-E microscope (330–380 nm excitation wavelength; Nikon, 21 
Melville, NY, USA). 22 
 23 
In vitro embryo production 24 
In vitro embryo production was performed as previously reported (Hussein et al., 25 





IVF medium. Frozen sperm samples (0.5 ml) were thawed at 37°C for 30 s and then 1 
centrifuged in a discontinuous Percoll (GE Healthcare, Piscataway, NJ USA) gradient 2 
(45%:90%) at 271 × g for 25 min. The pellet was then resuspended in wash medium and 3 
centrifuged at 56 × g for 5 min. Spermatozoa were resuspended in IVF medium, and 20 4 
µl of this suspension was added to 380 µl IVF medium containing COCs to yield a final 5 
concentration of 1 × 106 sperm/ml. After 20 h of culture (day 1), putative zygotes were 6 
mechanically denuded from cumulus cells and spermatozoa by gently pipetting using a 7 
glass pipette. A total of 5 zygotes were placed in a droplet of 20 µl of cleavage medium 8 
and cultured at 38.5°C in 6% CO2, 7% O2, nitrogen balance. On day 5 of culture, embryos 9 
were transferred into blastocyst medium. The rates of cleavage and blastocyst formation 10 
were calculated on day 2 and days 7 and 8, respectively. 11 
 12 
Differential staining of blastocyst inner cell mass and trophectoderm cells 13 
The allocation of cells within blastocysts was assessed by differential staining of 14 
ICM and TE cells as described previously (Hardy et al. , 1989). Briefly, the zona-pellucida 15 
was removed using 0.5% pronase at 37°C. Embryos were washed in wash medium 16 
minus protein and cultured in 10% 2,4,6-trinitrobenzene sulfonic acid for 10 min at 4°C 17 
in the dark. Embryos were then incubated in anti-2,4-dinitrophenol (1:10) for 10 min at 18 
37°C , followed by a 10-min incubation in complement (2 µg/ml of propidium 19 
iodine:guinea pig serum 1:1). Embryos were then fixed in ethanol containing 25 µg/ml 20 
Hoechst 33342. Fixed and stained embryos were mounted in 100% glycerol, and the 21 
number of ICM and TE cells was assessed under an epifluoresence microscope 22 
(excitation = 340-380 nm and emission = 440-480 nm). ICM and TE nuclei appear blue 23 
and pink, respectively. 24 
 25 





Cumulus expansion was assessed according to the scoring system of 1 
Vanderhyden et al. (1990). Briefly, a score of 0 indicates no detectable response; +1 2 
indicates minimum response, with cells in the peripheral 2 layers beginning to expand; 3 
+2 indicates expansion extending inwards to several layers; + 3 indicates expansion of 4 
all layers of cumulus except the corona radiata cells; and +4 indicates expansion of the 5 
entire cumulus including corona radiata cells. Cumulus expansion was examined at 3, 6, 6 
12 and 22 h of IVM. 7 
 8 
RNA extraction and real-time RT-PCR analysis 9 
HAS2, TNFIPA6, PTX3 and PTGS2 genes were analyzed by real-time PCR as 10 
previously described (Gilchrist and Ritter, 2011). Ribosomal protein L19 (RPL19) was 11 
used as the endogenous control, as this was found to be stably expressed regardless of 12 
the experimental treatments. COCs cultured for 3, 6, 12 and 22 h, were mechanically 13 
stripped of their cumulus cells by vigorous pipetting using a 200 µl pipette. Cumulus cells 14 
from 30 COCs were lysed in 300 µl of RTL buffer containing 10 µl/ml of 2-15 
mercaptoethanol and stored at -80°C until RNA extraction. Total RNA was extracted from 16 
each sample using the RNeasy Micro Kit (QIAGEN, Valencia, CA) according to the 17 
manufacturer’s instructions and quantified using a NanoDrop spectrophotometer 18 
(Thermo Fisher Scientific, Scoresby, VIC, Australia). Residual genomic DNA was 19 
removed by digesting with recombinant RNase-free DNase I (QIAGEN). RNA (200 ng) 20 
was reverse transcribed with random primers (Invitrogen) using Super-Script III 21 
(Invitrogen Australia Pty Limited, Mount Waverley, Australia). Quantitative real-time PCR 22 
analysis was performed on a Corbett Rotor-Gene 6000 (QIAGEN) in a 20-µl reaction 23 
volume containing 3 µl cDNA, 2.5 µl each of forward and reverse primers (Table 1), that 24 
were designed from bovine sequences, 2 µl nuclease-free water and 10 µl SYBR Green 25 





carried out in duplicate. Universal thermal cycling parameters (initial step of 2 min at 1 
50°C and 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 60 s at 60°C) were 2 
used to quantify the expression of all genes. At the end of the real-time PCR analysis, 3 
melting curve analysis was carried out on the real-time cycler to check the specificity of 4 
the reaction. A standard curve was generated for the gene of interest and for the 5 
endogenous control gene (RPL19) in every PCR run by using a serial 5-fold dilution of 6 
the amplified cDNA derived from cumulus cells. Final quantitative analysis of each gene 7 
was performed using the standard curve method and results were reported as a relative 8 
to the housekeeping gene RTL19.  9 
 10 
Glucose and lactate metabolism 11 
Glucose uptake and lactate production by COCs were determined by measuring 12 
the concentration of each substrate in the spent media as previously described (Sutton-13 
McDowall et al., 2012). After 22 h of culture, spent media samples were snap frozen and 14 
stored at −80°C. Glucose and lactate concentrations in 50 µl of spent media were 15 
determined using a Hitachi 912 chemical analyzer (F. Hoffmann-La Roche Ltd; Basal, 16 
Switzerland) and 10 media samples (10 COCs per 100 µl) were measured for each 17 
treatment. Glucose uptake and lactate production were expressed as pmol COC-1 h-1. 18 
 19 
Redox state 20 
Redox state in the oocyte was determined following measurement of 21 
autofluorescence emissions that relate to the concentration of NAD(P)H and FAD++, 22 
using methodologies previously described and validated (Dumollard et al. , 2004). After 23 
22 h of culture, COCs were denuded by gentle pipetting using a 200 µl pipette. Oocytes 24 
were washed twice in wash medium and transferred into 5 µl of wash medium overlaid 25 





intensity for autofluorescence detection (excitation: 405 nm, emission: 420–520 nm) and 1 
green (excitation: 473 nm, emission: 490–590 nm) was set at 50% maximal power and 2 
detection sensitivity was 75% (blue) and 65% (green), respectively. Images were 3 
captured at 40× magnification, 521 × 521 pixel image size and 8× speed/quality by using 4 
an Olympus Fluoview FV10i confocal microscope (Olympus; Tokyo, Japan). Microscope 5 
and image settings remained constant throughout. Fluorescence intensity was measured 6 
with FV10-ASW 3.0 software (Olympus). The intensity was normalized to the mean value 7 
of the background excluding oocytes in each photograph. Autofluorescence was also 8 
assessed in oocytes which were matured in groups of 10 denuded oocytes (DOs) or 5 9 
DOs co-cultured with 5 COCs.  10 
 11 
Gap junctional communication assay 12 
The degree of gap junction communication in COCs was assessed using lucifer 13 
yellow (LY) dye microinjected into the ooplasm, as previously described (Luciano et al. , 14 
2004). After 0, 3, 6 and 12 h of IVM, 3% LY in 5mM lithium chloride was microinjected 15 
into the oocyte. The spread of dye into the surrounding cumulus cells was assessed with 16 
the confocal microscope within 15 min of injection. As a positive control, the coupling of 17 
COCs was assessed immediately after collection, and as a negative control, COCs were 18 
cultured in IVM medium for 12 h supplemented with the gap-junction inhibitor, 19 
carbenoxolone (CBX, 100 µM) and assessed at 12 h. Individual COCs were scored as 20 
+2 when the dye was completely transferred to the entire cumulus mass, +1 when the 21 
dye was transferred to limited number of cumulus cell layers just beyond the corona 22 
radiata, and 0 when the dye was transferred to only the corona radiata cells or was not 23 
transferred to any cumulus cells at all (Fig. 6A). The average score of 10 COCs in each 24 






Statistical analysis 1 
Data were analyzed using analysis of variance (ANOVA) followed by Tukey-2 
Kramer test or Student t-test. All percentage data were arcsine transformed prior to 3 
ANOVA. For all data, P < 0.05 was considered significant. All analyses were conducted 4 
using StatView (SAS Institute Inc, NC, USA). 5 
 6 
Results 7 
Amphiregulin enhances oocyte developmental competence in the presence of 8 
exogenous oocyte-secreted factors 9 
The effect of AREG and FSH during the COC maturation phase in vitro on oocyte 10 
meiotic progression and subsequent embryo development were examined, firstly alone 11 
and then in the presence of native oocyte-secreted factors (denuded oocytes; DOs), 12 
recombinant GDF9 and BMP15 in their pro-mature form. Regardless of the presence or 13 
absence of native or recombinant oocyte-secreted factors, AREG and FSH 14 
supplementation did not affect the resumption and completion of oocyte nuclear 15 
maturation (Fig. S1).  16 
Post fertilization, there were no significant differences in embryo cleavage rates 17 
or the proportion of pre-compaction embryos across all treatments (P > 0.05; Fig. 1). In 18 
the absence of native or recombinant oocyte-secreted factors (Fig. 1A), FSH increased 19 
total blastocyst development 1.6-fold on day 8 (on time development) compared to the 20 
control, whereas AREG did not influence total blastocyst development on either day 7 or 21 
8. However, treatment of oocytes during maturation with AREG and with either DOs or 22 
BMP15 further increased total blastocyst development on both days 7 and 8, compared 23 
to the control group (P < 0.05; Figs. 1B and 1D). This additive effect of oocyte-secreted 24 
factor and AREG enhancing pre-implantation embryo development was not observed 25 





The FSH and AREG treatment groups had significantly higher rates of 1 
hatching/hatched blastocysts compared to the control group, in absence of oocyte-2 
secreted factors (Fig. 1A). 3 
Cell allocation to the inner cell mass cell lineage (ICM; fetal progenitor) or 4 
trophectoderm (TE; placenta progenitor cells) within blastocysts is an indicator of embryo 5 
health and predicts post-implantation embryo and fetal developmental potential 6 
(Sugimura et al. , 2012). In the absence of oocyte-secreted factors, there was no 7 
difference in the number of ICM and TE cells between the various experimental groups 8 
(P > 0.05; Fig. 2A). In contrast, the number of total and ICM cells in the subsequent 9 
blastocysts was significantly increased in the groups supplemented with AREG and DOs 10 
(Fig. 2B) or BMP15 (Fig. 2D) during the oocyte maturation phase, but not in the FSH 11 
group. As with embryo development, supplementation with GDF9 ± FSH ± AREG had 12 
no influence on embryo quality as assessed by ICM, TE and total cell numbers within 13 
blastocysts (Fig. 2C). 14 
 15 
Regulation of cumulus cell expansion by amphiregulin, FSH and BMP15    16 
Cumulus cell production of extracellular matrix proteins is a hallmark of the 17 
ovulatory cascade, and expression of some of the related genes are amongst the most 18 
reliable markers of oocyte developmental competence (Adriaenssens et al. , 2010, 19 
Wathlet et al. , 2011). We measured cumulus expansion and expression of relevant 20 
genes within cumulus cells of COCs treated with either FSH or AREG, with and without 21 
BMP15 (Fig. 3 and 4). As expected, cumulus expansion was observed from 12 h of 22 
oocyte maturation in both FSH- and AREG-treated groups (Fig. 3, A). Overall, BMP15 23 
did not promote morphological cumulus expansion or expression of any matrix gene, nor 24 
affect the capacity of FSH or AREG to do so (Fig. 4, B-E). The level of expansion in 25 





by the addition of BMP15 (Fig. 4A). FSH stimulated higher HAS2 expression than AREG, 1 
with maximum expression observed at 6 and 12 h of oocyte maturation (Fig. 3B). 2 
Consistent with the morphological measures of cumulus cell expansion, AREG did not 3 
alter cumulus cell HAS2 gene expression at any stage during COC maturation (Fig. 3B). 4 
TNFAIP6 expression within cumulus cells of the FSH-treated group was higher at 3 h 5 
than in the AREG treated group (P < 0.05; Fig. 3C). Furthermore, cumulus cells of FSH-6 
treated COCs at 22 h had higher TNFAIP6 expression compared with control, and 7 
although this response was not achieved with AREG alone it was with AREG combined 8 
with BMP15 (Fig. 4C). The expression level of PTX3 was significantly higher following 3 9 
h of oocyte maturation in the FSH stimulated group, but otherwise no difference was 10 
observed at any other time point (Figs. 3D). In both FSH and AREG stimulated groups, 11 
PTGS2 expression increased from 12 to 22 h (Fig. 3E). Expression level of PTGS2 at 22 12 
h did not differ with FSH or AREG stimulation (Fig. 4E). These results demonstrate that 13 
the slightly diminished cumulus cell expansion observed within the AREG-stimulated 14 
COCs correlated with less expression of extracellular matrix related genes, most notably 15 
an absence of change in HAS2 expression. 16 
 17 
Amphiregulin stimulates cumulus-oocyte complex glycolysis 18 
Within the COC, glucose is mostly metabolized to lactate via glycolysis for energy 19 
production and this primarily occurs within the cumulus cell compartment of the complex 20 
(Sutton-McDowall et al. , 2010). Glucose uptake, lactate production and lactate:glucose 21 
ratio were measured in COCs cultured with FSH or AREG in the presence or absence of 22 
BMP15 (Fig. 5). Theoretically, under conditions that enable complete glycolysis, two 23 
molecules of lactate are produced from one glucose molecule, hence the lactate:glucose 24 
ratio can indicate the proportion of glucose metabolized via glycolysis, as opposed to 25 





extent than FSH, as evidenced by higher levels of glucose consumption and lactate 1 
production (Figs. 5, A and B). BMP15 had no appreciable effect on COC glycolysis, 2 
although the combination of BMP15 and AREG stimulated more glucose consumption 3 
than those treated with FSH (P < 0.05; Fig. 5A). The ratio of lactate production to glucose 4 
uptake was significantly higher in AREG-treated COCs than in FSH-treated COCs, and 5 
the lactate:glucose ratio was further increased with the addition of BMP15 (P < 0.05; Fig. 6 
5C).  These results indicate that AREG stimulation of oocyte maturation results in a 7 
higher glycolytic activity compared with FSH-stimulation.  8 
 9 
NAD(P)H and FAD++ in oocytes is increased by the combination of AREG and 10 
BMP15 and requires cumulus cell-oocyte contact 11 
Monitoring oocyte autofluorescence of NAD(P)H and FAD++ provides information 12 
about oocyte metabolism and cellular REDOX state (Dumollard et al. , 2007). When 13 
oocytes were treated as intact COCs with the combination of BMP15 plus AREG, intra-14 
oocyte NAD(P)H and FAD++ levels were significantly increased, compared to the control 15 
group without BMP15 (COCs; Fig. 6, A1 and B1). No other combination of ligands altered 16 
oocyte NAD(P)H and FAD++ levels. No significant difference was found amongst 17 
experimental groups in the FAD++:NAD(P)H ratio (REDOX ratio; Fig. 6, C1). No 18 
difference was observed in oocyte NAD(P)H and FAD++ levels or the REDOX ratio (P > 19 
0.05) between treatments when oocytes were denuded of their cumulus cells prior to 20 
culture (DOs; Fig. 6, A2-C2). Similarly, these measures were unchanged in denuded 21 
oocytes that were exposed from the start of culture to intact COCs (DOs+COCs; Fig. 6, 22 
A3-C3), suggesting that a metabolic difference in COCs caused by the ligand treatments 23 
could not be transmitted by paracrine means to neighboring denuded oocyte in culture. 24 
These results suggest that the elevated levels of intra-oocyte NAD(P)H and FAD++, 25 





coupling of oocytes to cumulus cells, and is not the result of a direct action of the ligands 1 
on oocytes or paracrine secretions by cumulus cells to oocytes. 2 
 3 
BMP15 sustains cumulus-oocyte gap-junctional communication  4 
Because metabolic coenzymes levels were increased in oocytes within intact 5 
COCs following treatment with AREG and BMP15, but not within denuded oocytes (Fig. 6 
6), we next investigated the role of AREG and BMP15 in intercellular coupling of cumulus 7 
cells with oocytes by injecting lucifer yellow dye into the ooplasm (Fig. 7). Diffusion of the 8 
dye from the oocyte into cumulus cells is a standard measure of oocyte-CC GJC (Wert 9 
and Larsen, 1989). Prior to maturation (Fig. 7A), most COCs had open gap junctions 10 
(69.1% ± 3.2%) or at least partly open gap junctions (26.3% ± 5.4%), and few COCs had 11 
completely closed junctions (5.2% ± 3.4%).  The coupling index was 1.74 ± 0. 05 at this 12 
time point. The coupling index at 3 h and 6 h was significantly higher in groups treated 13 
with FSH and FSH+AREG than in the control and those treated with AREG (Fig. 7B). 14 
Levels of coupling in FSH and FSH+AREG groups remained steady until 3 h of oocyte 15 
maturation, unlike in the control and AREG groups, indicating that AREG could not 16 
maintain oocyte-CC GJC to levels maintained by FSH. No significant differences were 17 
observed among the experimental groups at 12 h, nor with COCs treated with the gap 18 
junction inhibitor carbenoxolone (CBX), indicating that oocyte-CC GJC in all groups was 19 
completely closed at 12 h of maturation. In the presence of BMP15 for 3 h, coupling 20 
indexes in the control and AREG groups were not different from that of the FSH group 21 
(Fig. 7C) and were similar to levels at 0 h. By 6 h of oocyte maturation, oocyte-CC 22 
coupling was sustained by FSH or by BMP15 alone or in combination with FSH or AREG. 23 
Taken together these results indicate that BMP15 has the capacity to sustain oocyte-CC 24 







The means by which oocytes acquire and maintain developmental competence 2 
is an extraordinarily complex, yet a fundamentally important biological process, as it sets 3 
the developmental life course for the ensuing embryo, fetus and offspring. During oocyte 4 
maturation in vivo and in reproductive medicine, where immature oocytes are removed 5 
from ovarian follicles and cultured as intact COCs prior to fertilization, hormones and 6 
growth factors control the fundamental processes of oocyte maturation (Gilchrist and 7 
Ritter, 2011). Previous studies in various animal models have shown that COCs cultured 8 
with either EGF-like factors (such as AREG and EREG (Prochazka et al., 2011, Richani 9 
et al., 2013)) or with OSFs (Hussein et al., 2006) have increased oocyte developmental 10 
competence. This is consistent with emerging critical roles of OSFs in regulating cumulus 11 
cell differentiation (Gilchrist et al. , 2008) and EGF-like factors mediating the endocrine 12 
ovulatory signal in the ovarian follicle (Conti et al. , 2006). However, our understanding 13 
of how EGF-like factors and OSFs may work together to regulate oocyte competence is 14 
limited. Here we demonstrate that AREG works cooperatively with BMP15 to enhance 15 
oocyte developmental competence, possibly by increasing the metabolite supply from 16 
the cumulus cells to the oocyte through extended gap-junction coupling. 17 
As summarized in Table 2, in the absence of any exogenous OSFs, both FSH 18 
and AREG during the oocyte maturation phase improved the hatching capacity of 19 
blastocysts. However, blastocyst formation could only be enhanced by FSH and not by 20 
AREG. In contrast, in the presence of either native OSFs (co-cultured DOs) or BMP15, 21 
AREG-treated COCs showed enhanced preimplantation development to the blastocyst 22 
stage, with increased blastocyst ICM numbers, compared with FSH treated COCs. This 23 
suggests that AREG works cooperatively with exogenous OSFs such as BMP15 to 24 
enhance oocyte developmental competence and via a different mode of action to that of 25 





human infertility and for advanced domestic animal breeding, as they suggest that the 1 
addition of either native or recombinant OSFs are more efficacious in AREG-stimulated 2 
oocyte maturation, than in the current universal practice of FSH-stimulated oocyte 3 
maturation.  4 
Numerous studies have now shown that native or recombinant OSFs, when 5 
added to IVM, enhance mammalian oocyte developmental competence. This suggests 6 
that the secretion or availability of resident OSFs from within the IVM COC is aberrant or 7 
deficient in some manner. In support of this, we have recently found that IVM mouse 8 
COCs, but not in vivo matured COCs, lack the processed form of BMP15 (Gilchrist et al; 9 
unpublished data), and that recombinant mouse GDF9 (in pro-mature complex form) 10 
improves mouse oocyte competence in the presence of FSH (Yeo et al., 2008). Unlike 11 
most members of the TGFβ superfamily, there are marked species-specific differences 12 
in the expression and bioactivity of GDF9 and BMP15 ligands. For example, the pro-13 
mature complex of human GDF9, but not mouse GDF9, is naturally latent and requires 14 
dissociation of the pro-mature complex for biological activity (Mottershead et al. , 2008, 15 
Simpson et al. , 2012). In the current study, we used human GDF9 and BMP15 proteins, 16 
as the bovine growth factors are not yet available and the human proteins are most 17 
relevant to future human applications. Moreover, as the species-specific expression and 18 
activity of these proteins is related to, or potentially determines, natural mammalian 19 
ovulation rate (Crawford and McNatty, 2012, McNatty et al. , 2005), human (c.f. murine) 20 
variants of GDF9 and BMP15 proteins are currently most relevant for bovine studies, as 21 
both species tend to be mono-ovular. Human GDF9 in the pro-mature form had little 22 
effect on oocyte competence (current study). This suggests that neither FSH- or AREG-23 
stimulated COCs are capable of activating latent human GDF9.  24 
Cumulus cell expansion, which plays a key role in normal fertilization (Fulop et 25 





cumulus cells surrounding the oocyte. An increase in the expression of the matrix genes 1 
HAS2 (Fulop et al. , 1997), TNFAIP6 (Fulop et al., 2003), PTX3 (Salustri et al. , 2004) 2 
and PTGS2 (Davis et al. , 1999) genes, which are stimulated by gonadotrophins or EGF-3 
like factors, is associated with normal cumulus expansion. In the present study, we 4 
observed that stimulation of COCs with AREG did not lead to an increase in the 5 
expression of HAS2 and TNFIPA6 as compared to those stimulated with FSH. In 6 
particular, HAS2 responded poorly to AREG-stimulation. Previous studies in pigs have 7 
also shown that cumulus cells of COCs treated with EGF-like factors, such as AREG, 8 
had lower expression levels of cumulus expansion related genes compared to FSH 9 
(Prochazka et al., 2011). Although both FSH and EGF-like factors activate MAPK1/3, 10 
PI3K/AKT and MAPK14 pathways via EGFR, EGF-like factors do not mimic all signals 11 
elicited by FSH in culture. EGF-like factors do not activate cAMP-PKA and do not 12 
stimulate progesterone production, as does FSH (Prochazka et al., 2011). This could be 13 
one of the reasons for the diminished cumulus expansion and lower expression levels of 14 
cumulus expansion-related genes in AREG-treated COCs seen in the present study. 15 
However, a recent study suggested that a PKA-independent pathway is involved in the 16 
regulation of HAS2 expression in cumulus cells (Prochazka et al., 2012). PKA is not the 17 
only transmitter of cAMP signals in mammalian cells (Gerdin and Eiden, 2007). PKA-18 
independent cAMP signaling has been recently reported in rat granulosa cells via Epac-19 
Rit (Wayne et al. , 2007). Thus, PKA-independent signaling bypassed in AREG 20 
stimulation may be associated with the reduced HAS2 expression.  21 
OSFs activate SMAD2/3 and/or SMAD1/5/8 signaling in cumulus cells; an event 22 
that is essential for cumulus expansion in the mouse (Buccione et al., 1990, Dragovic et 23 
al. , 2007). These events differ markedly in most other species where cumulus expansion 24 
is not critically depending on the presence of OSFs (Gilchrist and Ritter, 2011, Ralph et 25 





expansion of COCs in the absence or presence of FSH or AREG, nor did it alter FSH- or 1 
AREG-stimulated expression of genes associated with expansion.  2 
During the ovulatory cascade, cumulus expansion requires glucose, which is 3 
converted to UDP-N-acetyl glucosamine via the hexosamine biosynthesis pathway, and 4 
is necessary for hyaluronic acid production by HAS2 (Rilla et al. , 2013). Likewise, 5 
glucose metabolism via glycolysis in cumulus cells allows for ATP generation. Just as 6 
importantly, cumulus cell glycolysis generates metabolites such as pyruvate and lactate 7 
that can then be utilized by oocytes, which have a poor capacity to metabolize glucose 8 
(Donahue and Stern, 1968, Sutton-McDowall et al., 2010). Thus cumulus cell glycolysis 9 
and glucose consumption have fundamental roles in providing energy and substrates for 10 
oocyte metabolism that is necessary for subsequent post-fertilisation development. In 11 
the present study, both FSH and AREG stimulated glucose uptake and lactate production 12 
by COCs, regardless of BMP15 addition. However, glycolysis was stimulated to a greater 13 
extent in AREG-treated COCs and furthermore they exhibited a higher ratio of lactate 14 
production to glucose consumed compared to the FSH-treated group. This suggests that 15 
AREG may stimulate a higher proportion of glucose down the glycolytic pathway, and 16 
thereby possibly a reduction of glucose metabolism via the hexosamine biosynthesis 17 
pathway, a known “energy sensing” pathway.  Over-stimulation of the hexosamine 18 
biosynthetic pathway adversely affects oocyte developmental competence in cattle and 19 
pigs (Sutton-McDowall et al. , 2006) and in mice, over-stimulation promotes adverse 20 
long-term programming effects on fetal development (Schelbach et al. , 2010, Schelbach 21 
et al. , 2013). It is likely that AREG reduces glucose flux through the hexosamine pathway, 22 
consistent with the failure of AREG to stimulate HAS2 expression and reduced cumulus 23 
expansion, thus providing more ATP production from glycolysis within cumulus cells, 24 
compared to COCs treated with FSH. We propose this is one mechanism by which 25 





Pyruvate, lactate and glucose, that enter the oocyte from cumulus cells via 1 
glucose catabolism, are metabolised and can provide coenzymes such as NAD(P)H in 2 
the cytosol as well as in the mitochondria (Li et al. , 2011). Activation of the Kreb cycle 3 
by uptake of pyruvate in the mitochondria provides more NADH and leads to the 4 
reduction of FADH2 by oxidative phosphorylation via the electron transport chain, which 5 
is necessary for ATP production. On the other hand, NADPH from the pentose phosphate 6 
pathway reduces oxidized glutathione, a reaction important for maintaining antioxidant 7 
defense in the oocyte (de Matos et al. , 1997). Thus, changing the supply of energy 8 
substrates entering the oocyte from the cumulus cells should be reflected in levels of 9 
NAD(P)H and FAD++, (Dumollard et al., 2007). Although AREG increased glucose uptake 10 
and glycolysis in COCs, the intensity of NAD(P)H and FAD++ and the REDOX ratio in 11 
oocytes were similar to those observed in the control. However, in the presence of 12 
BMP15, their levels were increased by AREG stimulation.  This increase in the levels of 13 
NAD(P)H and FAD++ autofluorescence was not observed in denuded oocytes or denuded 14 
oocytes co-cultured with COCs upon stimulation with AREG and BMP15. This suggests 15 
that AREG increases metabolic activity in the oocyte cooperatively with BMP15 via 16 
oocyte-cumulus cell coupling and that these growth factors do not have this effect directly 17 
on the oocyte or via paracrine actions from cumulus cells.  18 
Oocyte-cumulus cell gap-junction coupling is vitally important for oocyte growth 19 
and is a key component of oocyte developmental competence (Gilchrist et al. , 2004). 20 
Intercellular communication in COCs can be regulated by dynamic changes in 21 
connexin43 (Cx43) and connexin37 (Cx37)-mediated gap-junction communication (GJC) 22 
(Sutovsky et al. , 1993, Veitch et al. , 2004). Cyclic AMP generated in cumulus cells 23 
stimulated by gonadotrophins or forskolin enhances the synthesis of Cx43 and GJC 24 
(Sasseville et al. , 2009, Thomas et al. , 2004). Furthermore, it is known that FSH 25 





via a PKA-depend pathway (Granot and Dekel, 1994, Yogo et al. , 2006, Yogo et al. , 1 
2002). In contrast to FSH, AREG is not thought to activate cAMP/PKA in cumulus cells 2 
(Prochazka et al., 2011). During the ovulatory cascade, LH-induced expression of AREG 3 
and EREG activates cumulus cell EGF receptors which in turn leads to closure of 4 
cumulus-oocyte gap junctions via a MAPK-dependent mechanism (Norris et al. , 2008, 5 
Norris et al. , 2010). These reports are consistent with the present study where we found 6 
that FSH but not AREG maintained cumulus-oocyte GJC. Perhaps surprisingly, BMP15 7 
prevented the normal closure of cumulus-oocyte GJC that occurs from 0 to 3 h of oocyte 8 
maturation and levels were still elevated by 6 h. This represents a previously undescribed 9 
role for BMP15 in oocyte biology. BMP15 even maintained GJC in the presence AREG, 10 
which typically is associated with closure of cumulus-oocyte gap junctions (Norris et al., 11 
2010). The intracellular mechanism by which BMP15 maintains cumulus-oocyte GJC will 12 
be an important issue for future studies. Nonetheless, in the current study, BMP15-13 
enhanced GJC may be an important means by which these oocytes achieve elevated 14 
levels of cumulus-derived metabolites that are vital for subsequent embryo development. 15 
In conclusion, the sophisticated communication axes and supply of metabolic 16 
substrates between the somatic cells and the germ cell of the COC are central to the 17 
oocyte’s capacity to support subsequent pre-implantation embryo development. Glucose 18 
uptake in cumulus cells stimulated by AREG may be utilized for the production of energy 19 
via glycolysis rather than being utilized for extracellular matrix and cumulus cell 20 
expansion. BMP15 maintains cumulus-oocyte GJC, possibly thereby allowing glycolytic 21 
metabolites to be more efficiently transferred to the oocyte from cumulus cells, facilitating 22 
oocyte energy production (Fig. 8). This may be the mechanism by which AREG in 23 
combination with BMP15 improves oocyte developmental competence, leading to 24 
improved embryo development. This knowledge has significant implications for 25 
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GenBank accession number Primer sequences forward (F) and reverse (R) Amplicon size 
(bp) 
HAS2 NM_174079.2 F: 5'-GGATCTCCTTCCTCAGCAGTGT-3' 106 
R: 5'-ATTCCCAGAGGTCCGCTAATG-3' 
TNFAIP6 NM_001007813.2 F: 5'-TGAAAGATGGGATGCATATTGC-3' 101 
R: 5'-CATTTGGGAAGCCTGGAGATT-3' 
PTX3 NM_001076259.2 F: 5'-CATGTATGTGAATTTGGACAACGA-3' 101 
R: 5'-GCTTGTCCCACTCGGAGTTC-3' 
PTGS2 NM_174445.2 F: 5'-CTTAAACAAGAGCATCCAGAATGG-3' 106 
R: 5'-GCTGTACGTAGTCTTCAATCACAATCT-3' 









Table II. Summary of the effects of treatment of oocytes during the maturation phase with FSH, growth factors and native 
oocyte-secreted factors, on oocyte maturation and subsequent embryo development and embryo quality. 
                      
Exogenous 
OSFs 
Ligands MII Cleaved <4 cell D7BL D8BL Hing/Hed Number of cells in blastocyst 
        Total ICM TE 
None 
 
FSH - - - - ↑ ↑ - - - 
AREG - - - - - ↑ - - - 
DOs FSH - - - - ↑ ↑ - - - 
 AREG - - - ↑ ↑ ↑ ↑ ↑ - 
GDF9 
 
FSH - - - - - ↑ - - - 
AREG - - - - - - - - - 
BMP15 
 
FSH - - - - ↑ ↑ - - - 





↑ and -, indicate a significant increase and no change to control, respectively; MII, % of oocytes to reache metaphase II; cleaved and <4 1 
cell, % of cleaved and <4 cell embryos, respectively; D7BL and D8BL, % of blastocysts at day 7 and 8 of cleaved embryos, respectively; 2 





Figure legends 1 
 2 
Fig. 1. Effect of FSH and AREG in the presence of oocyte-secreted factors during oocyte 3 
maturation on subsequent oocyte developmental competence. COCs were cultured 4 
without ligand (control) or with FSH or AREG supplemented medium, with either no 5 
oocyte-secreted factors (A); native oocyte-secreted factors (DOs; B); GDF9 (C); or 6 
BMP15 (D). Effects of treatments on oocyte development competence were examined 7 
by measuring the following points of embryo development: 2 cell cleavage (Cleaved), > 8 
4 cell embryos (>4 cell) at day 2, embryos developed to blastocysts at days 7 (D7BL) 9 
and 8 (D8BL), and those that reached the hatching or hatched blastocyst stage 10 
(Hing/Hed) by day 8. D7BL, D8BL and Hing/Hed are expressed as percentages of 11 
cleaved embryos. All values are represented as mean ± s.e.m of 7 replicate experiments. 12 
Asterisks indicate significant differences at P < 0.05. 13 
 14 
Fig. 2. Effect of FSH and AREG in the presence of oocyte-secreted factors during oocyte 15 
maturation on blastocyst cell number at day 8. COCs were cultured without ligand 16 
(control) or with FSH or AREG supplemented medium, with either no oocyte-secreted 17 
factors (A); native oocyte-secreted factors (DOs; B); GDF9 (C); or BMP15 (D). Effects 18 
of treatments during oocyte maturation on subsequent blastocyst quality were examined 19 
by counting the number of total, ICM and TE cells in blastocysts at day 8. All values are 20 
represented as mean ± s.e.m of 7 replicate experiments. Asterisks on the bars indicate 21 
significant differences at P < 0.05. 22 
 23 
Fig. 3. Kinetics of cumulus cell expansion and its related mRNA gene expression in 24 
cumulus cells treated with FSH or AREG. (A) Cumulus cell expansion index (CEI) in 25 





maturation. Values represented as mean ± s.e.m of 4 replicates. Asterisks indicate 1 
significant difference compared with AREG (P < 0.05; Student t-test). Expression of 2 
HAS2 (B), TNFIPA6 (C), PTX3 (D) and PTGS2 (E) in cumulus cells of COCs cultured in 3 
FSH or in AREG determined at various time points. FSH-treatment at 3 h was assigned 4 
a value of one and all other points are expressed relative to this point. Values are 5 
represented as mean ± s.e.m of 4 replicates. Asterisks indicate significant difference 6 
compared with AREG (P < 0.05; Student t-test).  7 
 8 
Fig. 4. Cumulus cell expansion and its related mRNA gene expression in cumulus cells 9 
treated with FSH or AREG in the presence or absence of BMP15. (A) CEI in COCs 10 
cultured with no ligand (control), FSH or AREG in the presence or absence of BMP15 11 
was examined at 22 h of oocyte maturation. Values are represented as mean ± s.e.m of 12 
4 replicates. Different letters indicate significant differences at P < 0.05. Expression of 13 
HAS2 (B), TNFIPA6 (C), PTX3 (D) and PTGS2 (E) in cumulus cells of COCs cultured 14 
with no ligand (control), FSH or AREG in the presence or absence of BMP15 were 15 
examined at 22 h of oocyte maturation. Control group in the absence of BMP15 was 16 
assigned a value of one and all other points are expressed relative to this point. Values 17 
are represented as mean ± s.e.m of 4 replicates. Different letters indicate significant 18 
differences at P < 0.05. 19 
 20 
Fig. 5. Glucose metabolism of COCs cultured with FSH or AREG in the presence or 21 
absence of BMP15. Glucose uptake (A), lactate production (B) and the ratio of lactate 22 
production to glucose uptake (C) were calculated from COCs cultured with no ligand 23 
(control), FSH or AREG in the presence or absence of BMP15 for 22 h of oocyte 24 
maturation. Values are represented as mean ± s.e.m of 5 replicates. Different letters 25 






Fig. 6. Regulation of oocyte NAD(P)H, FAD++ and redox ratio by ligands and cumulus-2 
oocyte contact. Intensity of oocyte autofluorescence of NAD(P)H (A1-A3) and FAD++ 3 
(B1-B3) and the redox ratio (C1-C3) in oocytes that were cultured 0-22h as intact COCs 4 
(COCs; A1-C1), or cultured 0-22h as denuded oocytes (DOs; A2-C2), or cultured 0-22h 5 
as denuded oocytes in co-culture with COCs (DOs+COCs; A3-C3). All cultures were 6 
treated with no ligand (control), FSH or AREG, in the presence or absence of BMP15. 7 
Within each graph, the control group in the absence of BMP15 was assigned a value of 8 
one and all other means are expressed relative to this value. Values are represented as 9 
mean ± s.e.m of 5 replicates. Different letters indicate significant differences at P < 0.05. 10 
 11 
Fig. 7. Regulation of oocyte-CC gap-junctional communication of COCs by FSH and 12 
AREG in the presence or absence of BMP15. (A) LY diffusion in COCs at 0 h of oocyte 13 
maturation. Fluorescence and bright field images of open (+2), partially open (+1), and 14 
closed (0) GJC. (B) LY diffusion in COCs cultured with no ligand (control), FSH, AREG 15 
or FSH+AREG was examined at 3, 6, and 12 of oocyte maturation in vitro. LY diffusion 16 
of COCs at 0 h and COCs cultured with CBX at 12 h were measured as positive (black) 17 
and negative controls (white). (C) LY diffusion in COCs cultured with no ligand (control), 18 
FSH or AREG in the presence or absence of BMP15, was examined at 3 h or 6 h of 19 
oocyte maturation in vitro. Dotted line indicates mean value at 0 h of IVM. Values are 20 
represented as mean ± s.e.m of 5 replicates. Different letters reflect significant 21 
differences within a time point at P < 0.05. Asterisks indicate significant differences 22 
compared to the GJC index at 0 h (P < 0.05; Student t-test). 23 
 24 
Fig. 8. Hypothesized mechanism by which AREG and BMP15 enhance oocyte 25 





TNFIPA6 are efficiently stimulated by FSH (A) but not by AREG (B). AREG with BMP15 1 
increase TNFIPA6 expression but not HAS2 expression (D). AREG enhances cumulus 2 
cell glucose metabolism via glycolysis (B) compared to FSH (A) but nonetheless leads 3 
to somewhat diminished cumulus expansion. Intra-oocyte oxidative phosphorylation is 4 
crucial for oocyte developmental competence and the oocyte is dependent on cumulus 5 
cells for supply of substrates from metabolized glucose via glycolysis. Accordingly, intra-6 
oocyte NAD(P)H and FAD++ levels are increased by the combination of AREG and 7 
BMP15 but only when cumulus cells and oocytes are physically coupled, which is 8 
sustained by BMP15 (D). Thus AREG and BMP15 cooperate to regulate oocyte 9 
metabolism by enhancing glycolysis and CC-oocyte gap-junctional communication, 10 
which increases oocyte developmental competence and the subsequent development 11 
and quality of embryos. 12 





Supplemental figure legends 1 
 2 
Fig. S1 Effect of FSH and AREG in the presence of OSFs on meiotic resumption. Bovine 3 
COCs were cultured in without ligand (control) and in FSH or AREG supplemented 4 
medium with no OSFs (A); DOs (B); GDF9 (C); and BMP15 (D). We examined the 5 
following: rates of oocytes arrested at the germinal vesicle stage (GV) and GVBD to 6 
telophase I (GVBD) and the percentage of cells that had reached metaphase II (MII) at 7 
22 h of IVM. All values are represented as mean ± s.e.m of 7 replicates.  8 
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Fig. 4. Sugimura et.



































































































































































































































































Fig. 7. Sugimura et.














































































































































































































































































































































































































































































































































Fig. S1. Sugimura et.
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